Capitainer enables patients to collect their own volume-defined dried blood spot at home.
Capitainer has raised $1.4M in total funding. The most recent round was Series A. The last funding was announced in February 2024.
Capitainer's investors include Sciety, EISMEA, We Venture Capital, Nordic Consumer Health, Sciety Venture Partners.
Capitainer is headquartered in Stockholm, Sweden.
Capitainer enables patients to collect their own volume-defined dried blood spot at home.
Capitainer is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Capitainer — Funding & Investors." VCBacked, February 15, 2024, https://www.vcbacked.co/company/capitainer. Accessed August 14, 2026.
VCBacked. (2024). Capitainer — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/capitainer
{{cite web |title=Capitainer — Funding & Investors |url=https://www.vcbacked.co/company/capitainer |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated